Calcium carbonate-conjugated polymer composite nanoparticles with anti-tumor and anti-metastasis effects and their application
By rupturing the calcium carbonate-conjugated polymer composite nanoparticles in a weakly acidic environment of tumors, releasing Ca2+ and conjugated polymers, combining photodynamic therapy and calcium overload mechanism, the side effects of existing cancer treatment on normal cells and tumor metastasis problems are solved, and efficient comprehensive cancer treatment is achieved.
Patent Information
- Application Number
- CN202310893463.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-07-20
- Publication Date
- 2025-08-08
- Estimated Expiration
- 2043-07-20
AI Technical Summary
Existing cancer treatment methods have negative effects on normal cells, and cancer metastasis is difficult to effectively inhibit. Traditional nanoplatforms have great side effects in tumor treatment, and the role of calcium ions in tumor cells has not been fully utilized.
A calcium carbonate-conjugated polymer composite nanoparticles were developed to encapsulate the conjugated polymer through calcium carbonate nanosphere shells, and rupture the tumor's weak acidic environment to release Ca2+ and conjugated polymers. Combined with photodynamic therapy and calcium overload mechanisms, they jointly kill tumor cells and inhibit metastasis.
It achieves efficient anti-tumor and anti-metastasis effects, significantly reduces tumor volume, inhibits tumor cell migration, and has good biocompatibility and safety.